Product Information
CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0679 per EA under NDC 70752010711. Its NADAC has been published 282 times since May 12, 2021.
FDA first approved this application on Feb 24, 2021. Its Orange Book therapeutic-equivalence code is AA.
Strength
4 mg/1
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752010711
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212491FDA Approved
2/24/2021
TE Code
AA
On Market Since
2/24/2021
Price Statistics
The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 282 times since May 12, 2021, and over the history we have for it it has declined 49.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0679 per EA |
|---|---|
| All-time high | $0.1349 (Jun 16, 2021) |
| All-time low | $0.0644 (Apr 22, 2026) |
| 52-week high | $0.0775 |
| 52-week low | $0.0644 |
| Median price | $0.0871 |
| Average price | $0.0859 |
| Largest weekly change | -25.5% (Jun 23, 2021) |
| Weeks tracked | 282 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CYPROHEPTADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Quagen Pharmaceuticals LLC, is $0.0679 per EA (NDC 70752010711), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 49.5%. It has been tracked across 282 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?
Since May 12, 2021, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.1349 (Jun 16, 2021), with a median of $0.0871 per EA.
Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYPROHEPTADINE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYPROHEPTADINE 4 MG TABLET?
CYPROHEPTADINE 4 MG TABLET (NDC 70752010711) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.